What is the current stock price of Cognetivity Neurosciences Ltd. (CGNSF)?

As of the latest market data, Cognetivity Neurosciences Ltd. (CGNSF) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does Cognetivity Neurosciences Ltd. (CGNSF) pay a dividend?

Based on current data, Cognetivity Neurosciences Ltd. does not have a confirmed active dividend policy.

What is the market cap of Cognetivity Neurosciences Ltd.?

The current market capitalization of Cognetivity Neurosciences Ltd. (CGNSF) is approximately unavailable.

CGNSF

Cognetivity Neurosciences Ltd.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Employees

2,500

IPO Date

2021-01-08

Beta

0.81

Websitewww.cognetivity.com↗